2721-LB: Obesity Switches Hepatic CB1 Signaling from Gi/oa-Mediated Lipolysis to Gsa-Driven Lipogenesis via the CREB-PPAR?-CD36-AMPK Axis
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2721-lb ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von JIE LIU und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Hepatocyte CB1 receptor (hCB1R) is implicated in obesity-induced steatotic liver disease (SLD), yet the molecular basis for its transition from homeostatic regulator to pathogenic driver remains unclear.
Objective
To investigate the functional reprogramming of hCB1R signaling in response to diet-induced obesity (DIO).
Methods
Using hCB1R knockout (hCB1Rko) mice and floxed controls, we evaluated the metabolic response to the peripheral CB1R antagonist JD5037. Transcriptomic profiling (RNA-Seq) and Western blotting were employed to map signaling pathways and protein expression profiles in lean versus steatotic liver environments.
Results
While chronic JD5037 treatment of DIO mice reduced body weight and hyperleptinemia in both genotypes, it reversed hepatic steatosis in control but not in hCB1Rko mice, demonstrating a weight-independent requirement for hCB1R in lipid metabolism. In lean mice, hCB1R couples to Gi/oα to suppress the CREB-PPARγ-CD36 axis that inhibits lipogenesis and desinhibits AMPK-induced fatty acid oxidation; however, in the steatotic liver, protein expression shifts, forcing CB1R to couple to Gsα. This signaling bifurcation activates the CREB-mediated transcriptional program, robustly upregulating Pparg and Cd36 and driving hepatic fatty acid accumulation.
Conclusion
Our data reveal that obesity reprograms hCB1R from a lipolytic Gi/oα-coupled receptor that protects from steatosis to a lipogenic Gsα-coupled driver of steatosis. Targeting this signaling switch may provide a more precise therapeutic strategy for the treatment of SLD. Disclosure J. Liu: None. G. Kunos: None. Funding Intramural funds of the National Institute on Alcohol Abuse and Alcoholism to George Kunos
Zitieren
APA
LIU, J., & KUNOS, G. (2026). 2721-LB: Obesity Switches Hepatic CB1 Signaling from Gi/oa-Mediated Lipolysis to Gsa-Driven Lipogenesis via the CREB-PPAR?-CD36-AMPK Axis. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2721-lb
Vancouver
LIU J, KUNOS G. 2721-LB: Obesity Switches Hepatic CB1 Signaling from Gi/oa-Mediated Lipolysis to Gsa-Driven Lipogenesis via the CREB-PPAR?-CD36-AMPK Axis. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2721-lb
BibTeX
@article{LIU2026,
author = {LIU, JIE and KUNOS, GEORGE},
title = {2721-LB: Obesity Switches Hepatic CB1 Signaling from Gi/oa-Mediated Lipolysis to Gsa-Driven Lipogenesis via the CREB-PPAR?-CD36-AMPK Axis},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2721-lb}
}
EUVIMED